Patent · US Active

Human binding molecules against enterococci and Staphylococcus

US8628776B2 · kind B2 · utility

5Cited by

13References

10Claims

0Family size

Assignee

Crucell Holland B.V. · NL

Inventors

Mark Throsby · Utrecht, NL
Robert A. Kramer · Crown Point, US
Cornelis Adriaan De Kruif · De Bilt, NL

Key dates

Filing date	Jul 16, 2012
Grant date	Jan 14, 2014
Priority date	—
Expiry date	Jul 16, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/21
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described are human binding molecules specifically binding to enterococci and having killing activity against enterococci, nucleic acid molecules encoding the human binding molecules, compositions comprising the human binding molecules and methods of identifying or producing the human binding molecules. The molecules can be used in the diagnosis, prophylaxis, and/or treatment of a condition resulting from Enterococcus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.